ScoreWhy is The Joint Corp. (United States) ?
1
High Management Efficiency with a high ROE of 17.91%
2
The company is Net-Debt Free
3
With a growth in Net Sales of 14.41%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 3 consecutive quarters
- PRE-TAX PROFIT(Q) At USD 0.52 MM has Grown at 207.18%
- NET PROFIT(Q) At USD 0.52 MM has Grown at 202.93%
- ROCE(HY) Highest at 10.64%
4
With ROE of 5.39%, it has a expensive valuation with a 7.85 Price to Book Value
- Over the past year, while the stock has generated a return of -17.34%, its profits have risen by 118.3% ; the PEG ratio of the company is 1
5
High Institutional Holdings at 89.6%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.22% over the previous quarter.
6
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -17.34% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to The Joint Corp. (United States) should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is The Joint Corp. (United States) for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
The Joint Corp. (United States)
-17.34%
-1.19
36.99%
S&P 500
16.06%
1.22
13.16%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.32%
EBIT Growth (5y)
-48.88%
EBIT to Interest (avg)
3.11
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-1.14
Sales to Capital Employed (avg)
3.79
Tax Ratio
4.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
88.38%
ROCE (avg)
25.28%
ROE (avg)
17.91%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
118
Industry P/E
Price to Book Value
7.85
EV to EBIT
94.01
EV to EBITDA
49.88
EV to Capital Employed
-10.38
EV to Sales
1.71
PEG Ratio
1.00
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
5.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
PRE-TAX PROFIT(Q)
At USD 0.52 MM has Grown at 207.18%
NET PROFIT(Q)
At USD 0.52 MM has Grown at 202.93%
ROCE(HY)
Highest at 10.64%
RAW MATERIAL COST(Y)
Fallen by -6.59% (YoY
NET SALES(Q)
Highest at USD 15.18 MM
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for The Joint Corp. (United States)
Pre-Tax Profit
At USD 0.52 MM has Grown at 207.18%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 0.52 MM has Grown at 202.93%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Highest at USD 15.18 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Raw Material Cost
Fallen by -6.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
